Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
HEICO Class A
HEI.A
|
$914M |
| 2 |
UnitedHealth
UNH
|
$677M |
| 3 |
Ferguson
FERG
|
$652M |
| 4 |
Apple
AAPL
|
$642M |
| 5 |
Visa
V
|
$628M |
Top Sells
| 1 |
Vale
VALE
|
$940M |
| 2 |
Pinduoduo
PDD
|
$546M |
| 3 |
Meta Platforms (Facebook)
META
|
$418M |
| 4 |
Mid-America Apartment Communities
MAA
|
$369M |
| 5 |
NetEase
NTES
|
$330M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3751
CEL-SCI Corp
CVM
$72.2M
| $61K | ﹤0.01% |
517
-12
| -2% | -$1.42K |
|
3752
Rekor Systems
REKR
$138M
| $61K | ﹤0.01% |
13,422
+192
| +1% | +$873 |
|
|
NNDM
3753
Nano Dimension
NNDM
$293M
| $61K | ﹤0.01% |
17,049
-3,596
| -17% | -$12.9K |
|
3754
Cue Biopharma
CUE
$59.9M
| $60K | ﹤0.01% |
12,437
-144
| -1% | -$695 |
|
3755
Alaunos Therapeutics
TCRT
$4.27M
| $60K | ﹤0.01% |
614
-19
| -3% | -$1.86K |
|
3756
Citius Pharmaceuticals
CTXR
$20.9M
| $59K | ﹤0.01% |
1,308
+28
| +2% | +$1.26K |
|
3757
Denison Mines
DNN
$2.11B
| $59K | ﹤0.01% |
36,694
-26,249
| -42% | -$42.2K |
|
3758
CorMedix
CRMD
$926M
| $58K | ﹤0.01% |
10,675
-228
| -2% | -$1.24K |
|
|
GRTS
3759
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $57K | ﹤0.01% |
13,885
-730,715
| -98% | -$3M |
|
|
HGEN
3760
DELISTED
HUMANIGEN, INC.
HGEN
| $57K | ﹤0.01% |
19,032
-146
| -0.8% | -$437 |
|
|
EXK
3761
Endeavour Silver
EXK
$1.74B
| $57K | ﹤0.01% |
12,399
-5,628
| -31% | -$25.9K |
|
3762
Ultrapar
UGP
$4.17B
| $57K | ﹤0.01% |
+18,651
| New | +$57K |
|
|
EAR
3763
DELISTED
Eargo, Inc. Common Stock
EAR
| $55K | ﹤0.01% |
+519
| New | +$55K |
|
3764
Outlook Therapeutics
OTLK
$41.5M
| $54K | ﹤0.01% |
1,527
-10
| -0.7% | -$354 |
|
3765
TherapeuticsMD
TXMD
$12.5M
| $54K | ﹤0.01% |
2,825
-3
| -0.1% | -$57 |
|
|
VIRX
3766
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $54K | ﹤0.01% |
11,377
+42
| +0.4% | +$199 |
|
|
PRTK
3767
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $54K | ﹤0.01% |
18,211
+765
| +4% | +$2.27K |
|
3768
Lineage Cell Therapeutics
LCTX
$279M
| $53K | ﹤0.01% |
34,518
-7,765
| -18% | -$11.9K |
|
|
AMRN
3769
Amarin Corp
AMRN
$317M
| $52K | ﹤0.01% |
791
+280
| +55% | +$18.4K |
|
3770
DURECT Corp
DRRX
$59.3M
| $51K | ﹤0.01% |
7,633
-176
| -2% | -$1.18K |
|
3771
Zevra Therapeutics
ZVRA
$502M
| $51K | ﹤0.01% |
+10,208
| New | +$51K |
|
3772
Smith Micro Software
SMSI
$15.5M
| $50K | ﹤0.01% |
1,656
+36
| +2% | +$1.09K |
|
3773
Viemed Healthcare
VMD
$267M
| $50K | ﹤0.01% |
10,128
-204
| -2% | -$1.01K |
|
3774
Q32 Bio
QTTB
$20.4M
| $48K | ﹤0.01% |
876
-904
| -51% | -$49.5K |
|
|
MTEM
3775
DELISTED
Molecular Templates, Inc.
MTEM
| $48K | ﹤0.01% |
920
+7
| +0.8% | +$365 |
|